Fox Run Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Fox Run Management's BIIB Position: Q4 2025 in Review
Fox Run Management sold out of Biogen (BIIB) in Q4 2025, closing a stake of 6,969 shares — an estimated $976K sold.
Fox Run Management first reported a position in BIIB in Q4 2018 and held it in 14 quarters. The position peaked at $1.62M in Q2 2025. 1,001 funds tracked by Wall St. Rank hold BIIB as of Q4 2025.
- Fox Run Management reported no remaining Biogen position as of Q4 2025 after selling out during the quarter.
- Fox Run Management sold 6,969 Biogen shares in Q4 2025, an estimated $976K.
- Fox Run Management first reported a position in Biogen in Q4 2018 and held it in 14 quarters.
- Fox Run Management's Biogen position peaked at $1.62M in Q2 2025.
- 1,001 funds tracked by Wall St. Rank held Biogen as of Q4 2025.
Based on Fox Run Management's 13F filing for Q4 2025, filed 11 Feb 2026.